Target intelligence / Profile preview

Mandible

Molecular classification
Other
01

Overview

The mandible is the largest and strongest bone of the human face, anatomically forming the lower jaw[1]. It serves essential functions in chewing and speech, supports the teeth, and forms the lower facial contour. Unlike other bones, it has a unique osteoimmune environment due to its exposure to the oral cavity and associated microbiota, influencing its response to injury, infection, and medications. It plays a critical role in dental and craniofacial growth and is a key focus in maxillofacial pathology and surgery. Recent research highlights its role in secreting extracellular vesicles that regulate early tooth development through epigenetic and cellular mechanisms[3]. The mandible is affected by targeted therapies such as bisphosphonates, which can lead to necrosis specific to this bone due to its unique physiology[1]. The mandible does not represent a standard therapeutic molecular target (such as a receptor, transporter, or enzyme). Any reference to "mandible" as a target for molecules or drugs is incorrect; molecular targets are typically proteins, nucleic acids, or other biomolecules, not whole organs or bones. If a query intends to specify a particular protein, cell surface marker, or signaling pathway in mandibular biology, a more precise name is required.

Other names
Lower jawMandibular bone
02

Biological functions

Mastication (chewing)Tooth support and jaw movementHouses bone marrow with immune functionsRegulation of tooth development via extracellular vesicles
03

Disease associations

Osteonecrosis of the jaw (e.g., bisphosphonate-related)Developmental disorders (mandibulofacial dysostosis)Infectious and inflammatory jaw conditions
04

Safety considerations

Susceptibility to osteonecrosis with antiresorptive therapies (bisphosphonates)Potential for impaired healing after dental procedures if exposed to certain medications
05

Interacting drugs

Bisphosphonates (indirectly affect mandible pathology by suppressing bone turnover)

Beyond the preview

Go deeper on Mandible.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mandible.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call